Regulatory T cells—an important target for cancer immunotherapy

被引：0
|
作者：
Charles G. Drake
Evan J. Lipson
Julie R. Brahmer
机构：
[1] Johns Hopkins University,Department of Oncology
来源：
Nature Reviews Clinical Oncology | 2014年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：307 / 307
相关论文
共 50 条
  • [31] T regulatory cells as an immunotherapy for transplantation
    Albert, MH
    Anasetti, C
    Yu, XZ
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (04) : 315 - 324
  • [32] Sublingual immunotherapy and regulatory T cells
    Ciprandi, G
    Fenoglio, D
    Cirillo, I
    Milanese, M
    Minuti, P
    ALLERGY, 2006, 61 (04) : 511 - 513
  • [33] Targeting regulatory T cells in gastric cancer: Pathogenesis, immunotherapy, and prognosis
    Wang, Bingyu
    Zhang, Zaibo
    Liu, Wenbo
    Tan, Bibo
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 158
  • [34] Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
    Tay, Christopher
    Tanaka, Atsushi
    Sakaguchi, Shimon
    CANCER CELL, 2023, 41 (03) : 450 - 465
  • [35] Antibody-based cancer immunotherapy by targeting regulatory T cells
    Li, Quanxiao
    Lu, Jun
    Li, Jinyao
    Zhang, Baohong
    Wu, Yanling
    Ying, Tianlei
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] Targeting lipid metabolism in regulatory T cells for enhancing cancer immunotherapy
    Yang, Liu
    Wang, Xingyue
    Wang, Shurong
    Shen, Jing
    Li, Yaling
    Wan, Shengli
    Xiao, Zhangang
    Wu, Zhigui
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2025, 1880 (02):
  • [37] The role of regulatory T cells in the Leishmania (Viannia) panamensis mouse model: a target for immunotherapy
    Ehrlich, Allison
    Castilho, Tiago
    Goldsmith-Pestana, Karen
    Sparwasser, Tim
    McMahon-Pratt, Diane
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [38] Phosphoinositide 3-kinaseδ is a regulatory T-cell target in cancer immunotherapy
    Lim, Ee Lyn
    Okkenhaug, Klaus
    IMMUNOLOGY, 2019, 157 (03) : 210 - 218
  • [39] The potential target of double negative T cells in cancer immunotherapy.
    Okamura, Kazumi
    Nagayama, Satoshi
    Tate, Tomohiro
    Kiyotani, Kazuma
    Nakamura, Yusuke
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Elimination of cDC1 cells by regulatory T cells jeopardizes cancer immunotherapy
    Liu, Peng
    Zhao, Liwei
    Kroemer, Guido
    Kepp, Oliver
    ONCOIMMUNOLOGY, 2024, 13 (01):
12345